Clinical Trial Update: New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a new oral anticoagulant to prevent venous thromboembolism after total hip or total knee replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• New Oral Anticoagulant Therapy

Snippet

Sponsor: Eli Lilly and Company | Conditions: Total Knee Replacement, Total Hip Replacement | Phase 2 | Status: COMPLETED